{"slideshow_credits": null, "snippet": "The premium and increased cash may help bring Allergan to the negotiating table. But questions over Valeant\u2019s own stock remain its weakness, says Robert Cyran of Reuters Breakingviews.", "abstract": "The premium and increased cash may help bring Allergan to the negotiating table. But questions over Valeant\u2019s own stock remain its weakness, says Robert Cyran of Reuters Breakingviews.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://dealbook.nytimes.com/2014/06/02/valeants-achilles-heel/", "lead_paragraph": null, "headline": {"main": "Valeant's Achilles' Heel", "kicker": "DealBook"}, "_id": "538cc49c38f0d8757fa21a7b", "word_count": "406", "multimedia": [{"height": 126, "url": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 373, "url": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "373"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/06/03/business/dbpix-allergan1/dbpix-allergan1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-06-02T14:37:43Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "2"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}